Primerica
Primerica, Inc.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$3.3B
Operating marginCalculated
Could not be retrieved
Net assets to total assetsCalculated
16.3%
Company profile
Tables scroll sideways
Disclosed data
Profitability
Could not be retrieved
Growth (revenue, 4-year average)
★★☆☆☆position among all companies
5.0%
Capital efficiency
Could not be retrieved
Revenue and profit
Performance, financial position and capital allocation
Primerica
Recent performance trends
Primerica
Cash flow trends
Consolidated indicators (8 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$2.7 billion | US$2.7 billion | US$2.7 billion | US$3.1 billion | US$3.3 billion |
| Net income | US$0.5 billion | US$0.5 billion | US$0.6 billion | US$0.5 billion | Could not be retrieved |
| Total assets | US$16.2 billion | US$14.6 billion | US$15.0 billion | US$14.6 billion | US$15.0 billion |
| Shareholders' equity | US$0.9 billion | US$2.0 billion | US$2.1 billion | US$2.3 billion | US$2.4 billion |
| Net cash provided by (used in) operating activities | US$0.7 billion | US$0.8 billion | US$0.7 billion | US$0.9 billion | US$0.9 billion |
| Net cash provided by (used in) investing activities | US$-0.9 billion | US$-0.2 billion | US$-90.05 million | US$-0.2 billion | US$-0.2 billion |
| Net cash provided by (used in) financing activities | US$0.1 billion | US$-0.5 billion | US$-0.5 billion | US$-0.6 billion | US$-0.6 billion |
| Cash and cash equivalents | US$0.4 billion | US$0.5 billion | US$0.6 billion | US$0.7 billion | US$0.8 billion |
Revenue scale in the same industry
Primerica
Insurance carriers: 54 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 UnitedHealth Group US$447.6B
- 2 Berkshire Hathaway US$371.4B
- 3 The Cigna Group US$274.9B
- … 47 companies
- 51 Alignment Healthcare US$3.9B
- 52 White Mountains Insurance Group US$3.7B
- 53 PrimericaThis company US$3.3B
- 54 Siriuspoint US$3.2B
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Cash and cash equivalents | US$0.8 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.6 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.9 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$19.25 million | Consolidated | Disclosed |
| Dividends paid | US$0.1 billion | Consolidated | Disclosed |
| Net assets | US$2.4 billion | Consolidated | Disclosed |
| Net sales | US$3.3 billion | Consolidated | Disclosed |
| Total assets | US$15.0 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.5 billion | Consolidated | Disclosed |
| Operating margin | Cannot be calculated | Not applicable | Not calculated (no operating income in this year's 10-K) |
| Net assets to total assets | 16.3% | Consolidated | Calculated |
| Net margin | Cannot be calculated | Not applicable | Not calculated (no net income in this year's 10-K) |
| Return on equity | Cannot be calculated | Not applicable | Not calculated (no net income in this year's 10-K) |